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Salivary proteins are an important source for developing marker-
based assays for oral cancers. To get an insight into the proteins
present in human saliva, we applied multiple strategies involving
afﬁnity-based depletion of abundant proteins, fractionation of the
resulting proteins or their tryptic peptides followed by LC–MS/MS
analysis, using high resolution mass spectrometry. By integrating
the protein identiﬁcations observed by us with those from similar
workﬂows employed in earlier investigations, we compiled an
updated salivary proteome. We have mapped the salivary
proteome to the published data on differentially expressed
proteins from oral cancer tissues and also for their secretory
features using prediction tools, SignalP 4.1, TMHMM 2c and
Exocarta. Proteotypic peptides for the subset of proteins implicated
in oral cancer and mapped to any two of the prediction tools for
secretory potential have been listed. The data here are relatedier Inc. This is an open access article under the CC BY license
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of potential biomarkers for oral cancer” in the Journal of
Proteomics [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Value of the data Proteins identiﬁed, compiled from published LC–MS/MS analysis and the data from our recent
analysis represent an updated salivary proteome. The list of salivary sub-proteome includes proteins which are reported to be differentially
expressed in oral cancer tissue specimens and have secretory potential. A high conﬁdence list of proteins along with their proteotypic peptides is supported by their
relevance in oral cancer and predicted secretory features. This subset would serve as an important reference for developing targeted analysis for clinical
applications.Speciﬁcations tableSubject area BiologyMore speciﬁc
subject areaSaliva proteomics or proteomeType of data Tables, excel ﬁles
How data was
acquiredFourier Transform LTQ-Orbitrap Velos mass spectrometer (Thermo Fischer Scientiﬁc, Bremen,
Germany) equipped with Proxeon Easy nLC was used for LC–MS/MS analysis
Proteome Discoverer 1.4 and SEQUEST search engine Human RefSeq 60 database
Human Oral Microbiome Database (HOMD)Data format Analyzed
Experimental factors Human saliva proteomic analysis, processing and fractionation of salivary proteins, mass
spectrometry, data analysis
Experimental
featuresHuman saliva from healthy subjects was subjected to depletion of high abundant proteins by starch
afﬁnity and/or antibody afﬁnity for plasmatic proteins or enrichment of low abundant proteins by
capturing with hexapeptide library. Pre-fractionation of proteins by SDS-PAGE followed by in-gel
tryptic digestion or SCX chromatography of tryptic peptides from in-solution digested total proteins.
Mass spectrometry was carried out using high resolution MS platform.Data source location Bangalore, India
Data accessibility Analyzed datasets are directly provided with this article2. Data, experimental design, materials and methods
2.1. Sample collection and processing
The study was approved by the Institutional Ethics Committee. The procedure for collection and
processing of saliva was adapted from earlier reports [2,3]. Brieﬂy, unstimulated saliva samples (5 ml) were
collected from healthy subjects of either sex in the age group between 20 and 50 years, with written
informed consent. The individuals selected were without any risk habits like tobacco chewing, smoking or
alcohol abuse. Samples were collected in the morning after rinsing the mouth with water and with subjects
refraining from food/drink for at least 1 h prior to the collection. All the samples were centrifuged at
2000 rpm, at 4 1C for 10 min to remove the cells. The supernatant was then collected and centrifuged at
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USA) as per the manufacturer's guidelines and the samples were stored at 80 1C until further use.2.2. Depletion and fractionation methods
Equal volumes of saliva were pooled based on the age groups and pooled saliva samples were
processed further. One pool included samples from individuals of 30–50 years of age, (Pool A) and the
other pool included samples from individuals of 20–30 years of age (Pool B). We adopted two
strategies to deplete abundant proteins. Depletion of amylase alone was carried out by using starch
afﬁnity-based amylase capture and depletion of amylase and plasmatic proteins by amylase capture
followed by antibody-based depletion of plasma proteins such as albumin, immunoglobulins and
others. The depleted protein fraction was then subjected to fractionation on SDS-PAGE and in-gel
tryptic digestion or in solution digested with trypsin and tryptic peptides were fractionated by SCX
chromatography. In another strategy, compression of the protein dynamic range of total salivary
proteins was carried out using hexapeptide library enrichment kit (ProteoMiner, Bio-Rad, CA, USA).
The tryptic digest of the enriched protein fraction was then subjected to fractionation by SCX
chromatography (See ﬁgure 1 in Ref [1] for details).
For amylase depletion, 5 ml of pooled saliva (approximately 5 mg of protein) was mixed with 1.5 g of
potato starch (Sigma Aldrich, MO, USA) [previously washed 3 times with water (3000 rpm, 5 min)] and
incubated for one hour in a rotating shaker, at room temperature. The mixture was then centrifuged at
3000 rpm for 5 min and the supernatant was collected. The pellet was washed again to recover trapped
saliva. Protein estimation was then carried out as mentioned above. Depletion of albumin, immunoglo-
bulins and any other abundant plasma proteins (transferrin, ﬁbrinogen, immunoglobulin A, haptoglobin,
alpha antitrypsin, alpha 2 macroglobulin, immunoglobulin M, apolipoprotein A1, alpha1 acid glycoprotein,
Complement C3, apolipoprotein A11 and transthyretin) was carried out using Human MARS-14 spin
cartridge (Agilent Technologies, CA, USA ) as per manufacturers' instructions. The protein sample after
amylase depletion was passed through the MARS-14 cartridge and the unbound protein was collected. The
procedure was repeated multiple times to collect approximately 500 μg of depleted protein fraction for
further experiments. Flow through fractions were collected, concentrated and desalted using a 5 kDaMW
cut off ultracentrifugal ﬁlter device (Amicon, Millipore, Billerica, MA). The protein concentration of the
sample was determined as mentioned above.
Two hundred micrograms of the above mentioned depleted saliva protein was resolved on a 10%
SDS-PAGE (1618 cm2) and the gel was stained using colloidal Coomassie blue. Twenty ﬁve gel slices
were excised and destained using 40 mM ammonium bicarbonate in 40% acetonitrile (ACN). The
sample was then subjected to reduction using 5 mM DTT (60 1C for 45 min) followed by alkylation
using 20 mM iodoacetamide (10 min. at room temperature). In-gel digestion with trypsin was carried
out at 37 1C for 12–16 h using modiﬁed sequencing grade Trypsin (Promega, WI, US). Peptides were
extracted from gel pieces sequentially using 5% formic acid, 5% formic acid in 40% ACN and ﬁnally with
100% ACN. The extracted peptides were dried and stored at 80 1C until LC–MS/MS analysis.
Alternatively, depleted protein fractionwas subjected to direct in-solution digestionwith trypsin and the
resulting peptides were fractionated by SCX chromatography. Brieﬂy, 200 mg of protein was reduced with
5 mMDTT and alkylated using 10 mM IAA as above. The proteins were then digested with trypsin as above
and the digested peptide mix was reconstituted in solvent A (10 mM potassium phosphate, 30% ACN, pH
2.7) and fractionation was carried out on a SCX column (Polysulfoethyl A column; 300 Å, 5 mm,
1002.1 mm2; PolyLC, MD, USA) using 1200 HPLC system (Agilent Technologies, CA, USA) coupled with a
binary pump, UV detector and a fraction collector. Peptides were eluted using a linear salt gradient (0 to
35%) of solvent B (10 mM potassium phosphate buffer containing 30% ACN, 350 mM KCl, pH 2.7) at a ﬂow
rate of 200 ml/ min. The adjacent fractions were then pooled based on the chromatographic proﬁle to make
the total number to 25. The samples were dried, reconstituted in 0.1% TFA and desalted using C18 stage-tip.
The desalted samples were dried and stored at 80 1C until further analysis.
For enrichment using ProteoMiner, salivary proteins were subjected to the procedure according to the
manufacturers' instructions (ProteoMiner; Bio-Rad, CA, USA). Brieﬂy, 10 mg of salivary protein was added to
the ProteoMiner column, incubated in a rotational shaker for 2 h at room temperature and centrifuged at
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buffer, by centrifugation at 1000 g for 1 min. Two hundred microlitres of deionized water was added and
centrifuged at 1000 g for 1 min. The enriched low abundant proteins bound to the columnwere eluted with
100 ml of rehydrated elution reagent, desalted using 5 kDaMW cut off ultracentrifugal ﬁlter device (Amicon,
Millipore, Billerica, MA) and protein estimation was carried out. The enriched protein sample was digested
in-solution with trypsin and the tryptic digest was subjected to SCX fractionation as described above.
2.3. LC–MS/MS analysis
Fourier-Transform LTQ-Orbitrap Velos mass spectrometer (Thermo Fischer Scientiﬁc, Bremen, Germany)
equipped with Proxeon Easy nLC was used for LC–MS/MS analysis. In house chromatographic capillary
columns made up of Magic C18 AQ reversed phase material (Michrom Bioresources, 5 and 3 μm, 100 Å)
were used for HPLC. Nanospray source with an emitter tip of 10 mm (New Objective, Woburn, MA) was
used for ionization with a voltage of 2 kV. Peptides were enriched on trap column (75 mm2 cm) at a ﬂow
rate of 3 mL/min using Solvent A (0.1% formic acid) followed by fractionation in an analytical column
(75 mm10 cm) to resolve the peptides. A linear gradient of 7–30% solvent B (0.1% formic acid, 95% ACN)
was used at a ﬂow rate of 350 nL/min., for 80 min. The mass spectrometry parameters used are as follows:
acquisition of the full scan data was implemented with a mass resolution of 60,000 at 400 m/z, top 20
intense peaks from each MS cycle were selected for MS/MS fragmentationwith a mass resolution of 15,000
at 400 m/z. Only multiple charged peptides were selected and 39% normalized collision energy was used
for fragmentation with 45 s exclusion time. Automatic gain control and ﬁlling time were kept at 5105
ions and 100 ms for MS, and 1105 ions and 500 ms for MS/MS, respectively. Polydimethylcyclosiloxane
(m/z, 445.1200025) ion was used for internal calibration [4].
2.4. Protein identiﬁcation and bioinformatics analysis
Mass spectrometry data was analyzed using Proteome Discoverer v1.4software (Thermo Scientiﬁc,
Bremen, Germany). Peak list ﬁle generation and database searches were carried out in SEQUEST mode.
Precursor mass range of 350–8000 Da and signal to noise ratio of 1.5 were used as the criteria for
generation of peak list ﬁles. Database searches for protein identiﬁcations were carried out for human
proteins using, NCBI Human RefSeq 60 protein database. As human saliva also contains microbial ﬂora,
a separate search was also carried out using combined database of NCBI Human RefSeq60 and oral
microbial proteins from the Human Oral Microbiome Database (HOMD; www.homd.org). We used the
searches against human protein database alone to identify all human proteins. The identiﬁcations
were compared with those from the combined database search and any shared peptides of microbial
protein origin identiﬁed were ﬁltered out to ensure that human protein identiﬁcations were
completely based on unique human peptides and microbial protein identiﬁcations were based on
unique microbial peptides. The human protein identiﬁcations from each of the 4 workﬂows used are
provided in Tables 1A–D. The list of non-redundant human and microbial proteins identiﬁed from all
the 4 workﬂows is provided in Tables 2 and 3, respectively.
The parameters used for database searches included trypsin as a protease with one missed cleavage,
carbamidomethyl cysteine as a ﬁxed modiﬁcation, and oxidation of methionine as a dynamic modiﬁcation.
Precursor ion and fragment ion mass error window used was 20 ppm and 0.1 Da, respectively. The proteins
and their corresponding peptide list were obtained using the criteria: peptide conﬁdence – high; peptide
rank – 1; Xcorr ﬁlters at individual MS runs to allow 1% FDR at peptide level with searches using decoy
database. Only unique peptides were considered for protein identiﬁcations. Further, all the single peptide
identiﬁcations were manually screened for the quality of spectra, peptide length and uniqueness. The single
peptide/protein hits were included only if the fragmentation was scored as good with respect to 70–80% of
‘b’ ion or ‘y’ ion information with optimal intensities and the peptides were at least 6 residues long.
Peptides, which have ambiguous spectra, were not included for valid identiﬁcations.
Gene Ontology (GO) classiﬁcation was done using HPRD (http://www.hprd.org) to classify identiﬁed
proteins for their subcellular localization, molecular function and biological processes (See ﬁgure 2 in Ref.
[1]). SignalP 4.1 (www.cbs.dtu.dk/services/SignalP) and TMHMM 2.0c (http://www.cbs.dtu.dk/ services/
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identiﬁed. The proteins were also compared with human exosomal protein database (Exocarta; http://
exocarta.org) [5].
2.4.1. Compilation of salivary proteome
Mass spectrometry-based proteomic studies using whole saliva or glandular saliva, varied depletion and
fractionation methods and instrumentation platforms (LC-MALDI TOF/TOF, LTQ-linear ion trap, LTQ-
Orbitrap XL and QSTAR Pulsar XL instruments) which varied in their analytical capabilities, were reported
by several research groups. [6–10]. Comprehensive cataloging of the salivary proteome was done by
combining the data from these earlier LC–MS/MS based studies on saliva along with the data from our
study (Table 4; also see ﬁgure 3 in Ref. [1]). Gene Ontology classiﬁcation and their secretory potential
analysis was carried out using the bioinformatics tools described above. Comparing the updated human
salivary proteome compiled and the differentially expressed proteins from oral cancer tissues from
published literature, we identiﬁed proteins implicated in oral cancer (Table 5). Further, the secretory
potential of these proteins was assessed based on the three criteria as described above i.e, exosomal, signal
peptide and transmembrane domain. This combined list of oral cancer relevant proteins which also map to
secretory potential is given in Table 5. From these, high conﬁdence secretory proteins were sorted that
matched to atleast two of the three secretory parameters. The proteotypic peptides/most observed peptides
of these proteins were selected from the Global Proteome Machine Database (GPMdb), along with their
additional peptides consistently observed in the multiple analysis datasets in the salivary proteome. They
are provided in Table 6 as high conﬁdence list for targeted analysis.Acknowledgments
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